PharmaSGP Holding SE (PSG) — Capital Reinvestment Ratio
PharmaSGP Holding SE (PSG) has a Capital Reinvestment Ratio of 0.17x as of March 2025, meaning it reinvests 0% of its operating cash flow (€4.22 Million) in capital expenditures (€708.00K). Check PharmaSGP Holding SE tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
PharmaSGP Holding SE Capital Reinvestment Ratio (2014–2024)
This chart tracks PharmaSGP Holding SE's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see how efficiently does PharmaSGP Holding SE generate cash.
Annual Capital Reinvestment Ratio for PharmaSGP Holding SE (2014–2024)
Year-by-year Capital Reinvestment Ratio for PharmaSGP Holding SE from 2014 to 2024. See PSG FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.06x | €24.88 Million | €1.47 Million | ▲ +82.0% |
| 2023 | 0.03x | €26.64 Million | €866.00K | ▲ +569.5% |
| 2022 | 0.00x | €24.71 Million | €120.00K | ▼ -36.8% |
| 2021 | 0.01x | €12.24 Million | €94.00K | ▼ -71.7% |
| 2020 | 0.03x | €15.46 Million | €420.00K | ▲ +14.1% |
| 2019 | 0.02x | €17.63 Million | €420.00K | ▼ -26.7% |
| 2018 | 0.03x | €8.43 Million | €274.00K | ▲ +16.7% |
| 2017 | 0.03x | €14.25 Million | €397.00K | ▼ -99.2% |
| 2016 | 3.35x | €3.55 Million | €11.88 Million | ▲ +731.2% |
| 2015 | 0.40x | €10.59 Million | €4.26 Million | ▲ +8.4% |
| 2014 | 0.37x | €5.41 Million | €2.01 Million | — |